NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Lupin Limited has announced the commercial launch of Sugammadex Injection in the United States following approval from the U.S. FDA. The product, a generic version of Merck's Bridion®, serves as a critical agent for reversing neuromuscular blockade in surgical patients.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
